Research showing the efficacy of a new three-drug cocktail that may help to treat ALS or Lou Gehrig's disease
You are invited to the announcement of breakthrough research showing the efficacy of a new three-drug cocktail that may help to treat ALS or Lou Gehrig's disease.
ALS is a steadily progressive and fatal neuromuscular disease that affects 1,500 to 2,000 people in Canada.
Two to three Canadians a day die of ALS.
Conducted at the Research Institute of the 成人VR视频 Health Centre and funded by the ALS Society of Canada and its partners in neuromuscular research, this research provides hope for people living with this devastating disease.
Date : |
Tuesday, April 1, 2003 |
When : |
10:30 a.m. |
Where : |
Osler Amphitheatre |
Who : |
Dr. Jean-Pierre Julien |
Several people living with ALS will also be available for interviews.